China’s New Strategy For Selling Drugs to Americans
The provided content appears to include a web page section with a “Read more…” button that, when clicked, reveals additional data. The extended content discusses china’s alleged utilization of cryptocurrency to profit from America’s steroid and peptide markets, highlighting concerns over unregulated peptide sales driven by Chinese manufacturers, some linked to opioid production. It details the U.S. regulatory efforts by the FDA and HHS to combat illegal marketing of unapproved drugs, including peptides and weight-loss treatments like GLP-1 drugs. The article also notes increased Chinese-based crypto sales and the risks associated with unregulated peptides, as emphasized by experts. Additionally, it addresses the ongoing fentanyl crisis in the U.S., with China identified as the primary source of trafficked fentanyl and related substances, which contribute to thousands of overdose deaths annually. The piece underscores the dangers of unapproved drugs and the complicating role of online cryptocurrency transactions in illegal drug distribution.
China is reportedly using cryptocurrency to take advantage of America’s steroid craze.
The Food and Drug Administration (FDA )’s Pharmacy Compounding Advisory Committee is scheduled to meet this Thursday and Friday to discuss whether seven peptides — loosely regulated protein-building chemicals — may be added to the Section 503A Bulks List, which determines what drugs medical professionals can use to create custom prescriptions. This comes as blockchain analysis firm Chainalysis found that one of the same Chinese manufacturers responsible for producing opioids like fentanyl is driving online peptide sales, Axios reported July 7.
“Under the Trump Administration, HHS [U.S. Department of Health and Human Services] and the FDA are committed to protecting Americans by ensuring that drugs marketed in the United States meet the applicable standards for safety,” an HHS spokesperson told the Daily Caller News Foundation. “The FDA continues to use its regulatory and enforcement authorities to address the illegal marketing and distribution of unapproved drugs, including products marketed as peptides for human use. These actions include warning letters, import controls, inspections, seizures, injunctions, and coordination with federal, state, and international partners, as appropriate.”
As crypto sales are harder to track than traditional banks, Chinese-based companies were able to reap approximately $27 million in the first quarter of 2026, according to Chainalysis. This is up 150% from the previous quarter.
Around half of American adults get their health advice from wellness influencers on social media, according to a study published by the Pew Research Center in May.
“For these manufacturers that decided to pivot, it was really a business decision,” Chainalysis senior intelligence analyst Sara Graham said, according to Axios. “They departed from a trade in which they could be sanctioned or indicted by the U.S. and reappeared in a very lucrative scene that has widespread buy-in.”
The FDA previously warned against using unapproved GLP-1 drugs — peptides designed for weight loss — and other custom drugs, citing concerns that counterfeit products may lack the safety and quality standards that FDA-approved ones like Ozempic or Trulicity uphold.
“I’m gobsmacked by the risks people are taking,” Nuritas CEO Nora Khaldi said, according to Axios. Nuritas specializes in designing organic peptides. “No matter how great a molecule is, the risk you’re taking by using and taking it when you don’t know the quality.… It’s mind-blowing.”
Synthetic opioid overdoses — primarily fentanyl— killed approximately 38,000 Americans in 2025, according to a study published by the Centers for Disease Control in May.
“China remains the primary source of fentanyl and fentanyl-related substances trafficked through international mail and express consignment operations environment, as well as the main source for all fentanyl-related substances trafficked into the United States,” according to a 2020 report published by the Drug Enforcement Agency.
All content created by the Daily Caller News Foundation, an independent and nonpartisan newswire service, is available without charge to any legitimate news publisher that can provide a large audience. All republished articles must include our logo, our reporter’s byline and their DCNF affiliation. For any questions about our guidelines or partnering with us, please contact [email protected].
Advertise with The Western Journal and reach millions of highly engaged readers, while supporting our work. Advertise Today.
" Conservative News Daily does not always share or support the views and opinions expressed here; they are just those of the writer."
*As an Amazon Associate I earn from qualifying purchases
